Literature DB >> 7688157

Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels.

R Romeo1, V Thiers, F Driss, P Berthelot, B Nalpas, C Brechot.   

Abstract

The pattern of hepatitis C virus (HCV) viremia in blood donors who are positive for antibody to HCV (anti-HCV) according to the level of transaminase activity is unclear. A polymerase chain reaction-based HCV RNA detection method was used to study two clearly defined groups of anti-HCV-positive blood donors with repeatedly normal (n = 27) and elevated (n = 17) alanine aminotransferase (ALT) levels. HCV RNA was detected in only 4 of 27 blood donors with normal ALT values and 15 of 17 with elevated ALT values. These results indicate that anti-HCV-positive blood donors with normal ALT levels constitute a heterogeneous group, as HCV viremia is detectable in only a small proportion of cases. Polymerase chain reaction should be useful in the surveillance of anti-HCV-positive blood donors with normal ALT levels, by identifying those who might benefit from further investigation and treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688157     DOI: 10.1046/j.1537-2995.1993.33893342742.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.

Authors:  G Gerken; T Rothaar; M G Rumi; R Soffredini; M Trippler; M J Blunk; A Butcher; S Soviero; G Colucci
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Detection of anti-hepatitis C-virus antibodies and hepatitis C-virus RNA in Lebanese hemodialysis patients.

Authors:  G E Abdelnour; G M Matar; H M Sharara; A M Abdelnoor
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

Review 3.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.